atai Life Sciences (ATAI) Tops Q3 EPS by 45c

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of $0.25, $0.45 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• Lennar Corp. (LEN) Misses Q2 EPS by 1c